SCHEMBL24672851

SCHEMBL24672851

C[C@H](O)CN1CCN(Cc2ccccc2S(=O)(=O)O)CCN([C@H](CO)[C@H](O)CO)CC1

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MC4R P32245 1/20 0.35
DRD2 P14416 2/20 0.34
APOBEC3A P31941 1/20 0.34
RECQL P46063 1/20 0.34
APOBEC3G Q9HC16 1/20 0.34
DRD4 P21917 1/20 0.34
DRD3 P35462 1/20 0.34
SLC6A3 Q01959 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
HTR1A P08908 1/20 0.34
HTR7 P34969 1/20 0.34
ADRA2A P08913 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24672850 0.92 MPO (0.38) APOBEC3ARECQLAPOBEC3GMEN1KMT2A
SCHEMBL29943098 0.92 MPO (0.38) APOBEC3ARECQLAPOBEC3GMEN1KMT2A
SCHEMBL24672239 0.88 MPO (0.41) DRD2DRD4DRD3SLC6A3MEN1
SCHEMBL24673201 0.83 MPO (0.52) MC4RDRD2APOBEC3ARECQLAPOBEC3G
SCHEMBL24672258 0.79 KDM4E (0.51) MC4RAPOBEC3ARECQLAPOBEC3GMEN1
SCHEMBL24672677 0.74 MPO (0.63) MEN1KMT2AATM
SCHEMBL24672676 0.74 MPO (0.63) MEN1KMT2AATM
SCHEMBL24673205 0.73 MPO (0.33) DRD2DRD4DRD3SLC6A3
SCHEMBL24673200 0.73 PKM (0.43) DRD2APOBEC3ARECQLAPOBEC3GDRD3
SCHEMBL24673196 0.73 HDAC1 (0.47) APOBEC3ARECQLAPOBEC3GMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022204065-A1 IRON(III) MACROCYCLIC COMPLEXES WITH MIXED HYROXYL PENDANTS AS MRI CONTRAST AGENTS THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2022-09-29 WO disclosed